Mallinckrodt to buy Questcor in cash-and-shares deal
April 07, 2014 at 07:43 AM EDT
Mallinckrodt is buying Questcor Pharmaceuticals for about $5.2 billion in cash and stock, in a deal expected to expand the scale and diversification of the specialty pharmaceutical company.
